2-(2-[Ethyl(methyl)amino]ethoxy)ethan-1-ol, 95%, 250mg

DL-Homophenylalanine methyl ester hydrochloride, 98.0%, 25g

E-plan EPL 10x/0.25 objective

2-Cyclopentyl-2-oxoacetic acid, 97%, 1g

2-Bromo-7-chlorothieno[3,2-b]pyridine, 95.0%, 10g

Titanium (diisopropoxide) bis (2,4-pentanedionate), 75% in isopropanol 500 g

Methyl-�-D-glucopyranoside hemihydrate, 98.0%, 5g

Methyl 1H-indole-7-carboxylate, 97.0%, 100g

2-Naphthalenecarboxylic acid, 6-(4-hydroxy-3-tricyclo[3.3.1.13,7]dec-1-ylphenyl)-, 98%, 10mg

1-(tert-Butyl) 2-methyl (2S,4R)-4-benzamidopyrrolidine-1,2-dicarboxylate, 98%, 50mg

2-(HYDROXYMETHYL)-3-NITROPYRIDINE, 97%, 250mg

2,6-Dibromoanthraquinone>95.0%(HPLC)1g

Danger signs SEKUROKA® Radioactive, 1 Roll